ID   SYSC_HUMAN              Reviewed;         514 AA.
AC   P49591; B2R6Y9; Q5T5C8; Q9NSE3;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=Serine--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.11;
DE   AltName: Full=Seryl-tRNA synthetase;
DE            Short=SerRS;
DE   AltName: Full=Seryl-tRNA(Ser/Sec) synthetase;
GN   Name=SARS; Synonyms=SERS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=9431993; DOI=10.1111/j.1432-1033.1997.00077.x;
RA   Vincent C., Tarbouriech N., Haertlein M.;
RT   "Genomic organization, cDNA sequence, bacterial expression, and
RT   purification of human seryl-tRNA synthase.";
RL   Eur. J. Biochem. 250:77-84(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Shiba K., Yu R., Motegi H., Martinis S., Noda T.;
RT   "Isolation and characterization of human seryl-tRNA synthetase cDNA.";
RL   Submitted (MAR-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-323, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   VARIANT ASN-172, CHARACTERIZATION OF VARIANT ASN-172, FUNCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF THR-429.
RX   PubMed=28236339; DOI=10.1002/humu.23205;
RA   Musante L., Puettmann L., Kahrizi K., Garshasbi M., Hu H., Stehr H.,
RA   Lipkowitz B., Otto S., Jensen L.R., Tzschach A., Jamali P.,
RA   Wienker T., Najmabadi H., Ropers H.H., Kuss A.W.;
RT   "Mutations of the aminoacyl-tRNA-synthetases SARS and WARS2 are
RT   implicated in the aetiology of autosomal recessive intellectual
RT   disability.";
RL   Hum. Mutat. 0:0-0(2017).
CC   -!- FUNCTION: Catalyzes the attachment of serine to tRNA(Ser) in a
CC       two-step reaction: serine is first activated by ATP to form Ser-
CC       AMP and then transferred to the acceptor end of tRNA(Ser). Is also
CC       probably able to aminoacylate tRNA(Sec) with serine, to form the
CC       misacylated tRNA L-seryl-tRNA(Sec), which will be further
CC       converted into selenocysteinyl-tRNA(Sec)(PubMed:9431993,
CC       PubMed:28236339). {ECO:0000269|PubMed:28236339,
CC       ECO:0000269|PubMed:9431993}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-serine + tRNA(Ser) = AMP + diphosphate
CC       + L-seryl-tRNA(Ser).
CC   -!- CATALYTIC ACTIVITY: ATP + L-serine + tRNA(Sec) = AMP + diphosphate
CC       + L-seryl-tRNA(Sec).
CC   -!- PATHWAY: Aminoacyl-tRNA biosynthesis; selenocysteinyl-tRNA(Sec)
CC       biosynthesis; L-seryl-tRNA(Sec) from L-serine and tRNA(Sec): step
CC       1/1.
CC   -!- SUBUNIT: Homodimer. The tRNA molecule binds across the dimer (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:28236339}.
CC   -!- TISSUE SPECIFICITY: Brain. {ECO:0000269|PubMed:28236339}.
CC   -!- DOMAIN: Consists of two distinct domains, a catalytic core and a
CC       N-terminal extension that is involved in tRNA binding.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase
CC       family. Type-1 seryl-tRNA synthetase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X91257; CAA62635.1; -; mRNA.
DR   EMBL; D49914; BAA95602.1; -; mRNA.
DR   EMBL; AK312771; BAG35636.1; -; mRNA.
DR   EMBL; AL356389; CAI13599.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56369.1; -; Genomic_DNA.
DR   EMBL; BC000716; AAH00716.1; -; mRNA.
DR   EMBL; BC009390; AAH09390.1; -; mRNA.
DR   CCDS; CCDS795.1; -.
DR   PIR; G01026; G01026.
DR   RefSeq; NP_006504.2; NM_006513.3.
DR   UniGene; Hs.531176; -.
DR   PDB; 3VBB; X-ray; 2.89 A; A/B/C/D/E/F=1-514.
DR   PDB; 4L87; X-ray; 2.90 A; A=2-477.
DR   PDB; 4RQE; X-ray; 4.00 A; A/C=1-514.
DR   PDB; 4RQF; X-ray; 3.50 A; A/B=1-514.
DR   PDBsum; 3VBB; -.
DR   PDBsum; 4L87; -.
DR   PDBsum; 4RQE; -.
DR   PDBsum; 4RQF; -.
DR   ProteinModelPortal; P49591; -.
DR   SMR; P49591; -.
DR   BioGrid; 112208; 59.
DR   DIP; DIP-38215N; -.
DR   IntAct; P49591; 13.
DR   STRING; 9606.ENSP00000234677; -.
DR   DrugBank; DB00133; L-Serine.
DR   iPTMnet; P49591; -.
DR   PhosphoSitePlus; P49591; -.
DR   SwissPalm; P49591; -.
DR   BioMuta; SARS; -.
DR   DMDM; 19860217; -.
DR   EPD; P49591; -.
DR   MaxQB; P49591; -.
DR   PaxDb; P49591; -.
DR   PeptideAtlas; P49591; -.
DR   PRIDE; P49591; -.
DR   DNASU; 6301; -.
DR   Ensembl; ENST00000234677; ENSP00000234677; ENSG00000031698.
DR   GeneID; 6301; -.
DR   KEGG; hsa:6301; -.
DR   UCSC; uc001dwu.3; human.
DR   CTD; 6301; -.
DR   DisGeNET; 6301; -.
DR   GeneCards; SARS; -.
DR   HGNC; HGNC:10537; SARS.
DR   HPA; HPA016939; -.
DR   HPA; HPA064668; -.
DR   MIM; 607529; gene.
DR   neXtProt; NX_P49591; -.
DR   OpenTargets; ENSG00000031698; -.
DR   PharmGKB; PA34945; -.
DR   eggNOG; KOG2509; Eukaryota.
DR   eggNOG; COG0172; LUCA.
DR   GeneTree; ENSGT00790000123098; -.
DR   HOGENOM; HOG000035937; -.
DR   HOVERGEN; HBG023172; -.
DR   InParanoid; P49591; -.
DR   KO; K01875; -.
DR   PhylomeDB; P49591; -.
DR   TreeFam; TF300762; -.
DR   BRENDA; 6.1.1.11; 2681.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   UniPathway; UPA00906; UER00895.
DR   ChiTaRS; SARS; human.
DR   GeneWiki; SARS_(gene); -.
DR   GenomeRNAi; 6301; -.
DR   PMAP-CutDB; P49591; -.
DR   PRO; PR:P49591; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000031698; -.
DR   CleanEx; HS_SARS; -.
DR   ExpressionAtlas; P49591; baseline and differential.
DR   Genevisible; P49591; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; TAS:ProtInc.
DR   GO; GO:0098619; F:selenocysteine-tRNA ligase activity; TAS:Reactome.
DR   GO; GO:0004828; F:serine-tRNA ligase activity; IMP:UniProtKB.
DR   GO; GO:0016259; P:selenocysteine metabolic process; TAS:Reactome.
DR   GO; GO:0097056; P:selenocysteinyl-tRNA(Sec) biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006434; P:seryl-tRNA aminoacylation; IBA:GO_Central.
DR   GO; GO:0006412; P:translation; TAS:ProtInc.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   GO; GO:0008033; P:tRNA processing; TAS:ProtInc.
DR   CDD; cd00770; SerRS_core; 1.
DR   Gene3D; 1.10.287.40; -; 1.
DR   InterPro; IPR002314; aa-tRNA-synt_IIb.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR002317; Ser-tRNA-ligase_type_1.
DR   InterPro; IPR015866; Ser-tRNA-synth_1_N.
DR   InterPro; IPR033729; SerRS_core.
DR   InterPro; IPR010978; tRNA-bd_arm.
DR   PANTHER; PTHR11778; PTHR11778; 1.
DR   Pfam; PF02403; Seryl_tRNA_N; 1.
DR   Pfam; PF00587; tRNA-synt_2b; 1.
DR   PRINTS; PR00981; TRNASYNTHSER.
DR   SUPFAM; SSF46589; SSF46589; 2.
DR   TIGRFAMs; TIGR00414; serS; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Aminoacyl-tRNA synthetase; ATP-binding;
KW   Complete proteome; Cytoplasm; Disease mutation; Ligase;
KW   Nucleotide-binding; Phosphoprotein; Protein biosynthesis;
KW   Reference proteome.
FT   CHAIN         1    514       Serine--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000122191.
FT   NP_BIND     302    304       ATP. {ECO:0000250}.
FT   NP_BIND     391    394       ATP. {ECO:0000250}.
FT   REGION      271    273       Serine binding. {ECO:0000250}.
FT   BINDING     318    318       ATP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     325    325       Serine. {ECO:0000250}.
FT   BINDING     429    429       Serine. {ECO:0000269|PubMed:28236339}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     241    241       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     323    323       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT     172    172       D -> N (probable disease-associated
FT                                mutation found in a family with moderate
FT                                intellectual disability, microcephaly,
FT                                ataxia, speech impairment and aggressive
FT                                behaviour; impaired serine-activation of
FT                                enzyme resulting in a significant
FT                                decrease in the first step of the
FT                                aminoacylation reaction; reduced protein
FT                                stability; reduced protein expression).
FT                                {ECO:0000269|PubMed:28236339}.
FT                                /FTId=VAR_078434.
FT   MUTAGEN     429    429       T->A: Catalytically inactive. Loss of
FT                                serine binding.
FT                                {ECO:0000269|PubMed:28236339}.
FT   CONFLICT     54     54       N -> S (in Ref. 1; CAA62635).
FT                                {ECO:0000305}.
FT   CONFLICT    435    435       R -> C (in Ref. 6; AAH09390).
FT                                {ECO:0000305}.
FT   HELIX         5      7       {ECO:0000244|PDB:3VBB}.
FT   HELIX        10     12       {ECO:0000244|PDB:3VBB}.
FT   HELIX        16     25       {ECO:0000244|PDB:3VBB}.
FT   HELIX        31     70       {ECO:0000244|PDB:3VBB}.
FT   HELIX        82     84       {ECO:0000244|PDB:3VBB}.
FT   STRAND       86     89       {ECO:0000244|PDB:3VBB}.
FT   HELIX        92     96       {ECO:0000244|PDB:3VBB}.
FT   STRAND      100    102       {ECO:0000244|PDB:3VBB}.
FT   HELIX       103    112       {ECO:0000244|PDB:3VBB}.
FT   HELIX       118    131       {ECO:0000244|PDB:3VBB}.
FT   HELIX       132    134       {ECO:0000244|PDB:3VBB}.
FT   HELIX       149    152       {ECO:0000244|PDB:3VBB}.
FT   STRAND      154    160       {ECO:0000244|PDB:3VBB}.
FT   HELIX       170    176       {ECO:0000244|PDB:3VBB}.
FT   HELIX       183    189       {ECO:0000244|PDB:3VBB}.
FT   STRAND      195    197       {ECO:0000244|PDB:3VBB}.
FT   HELIX       199    217       {ECO:0000244|PDB:3VBB}.
FT   STRAND      221    224       {ECO:0000244|PDB:3VBB}.
FT   STRAND      227    230       {ECO:0000244|PDB:3VBB}.
FT   HELIX       231    237       {ECO:0000244|PDB:3VBB}.
FT   HELIX       240    245       {ECO:0000244|PDB:4L87}.
FT   STRAND      249    252       {ECO:0000244|PDB:3VBB}.
FT   STRAND      254    256       {ECO:0000244|PDB:4L87}.
FT   STRAND      266    268       {ECO:0000244|PDB:3VBB}.
FT   HELIX       273    277       {ECO:0000244|PDB:3VBB}.
FT   TURN        278    282       {ECO:0000244|PDB:4L87}.
FT   STRAND      283    285       {ECO:0000244|PDB:4L87}.
FT   TURN        287    289       {ECO:0000244|PDB:3VBB}.
FT   STRAND      292    301       {ECO:0000244|PDB:3VBB}.
FT   STRAND      308    311       {ECO:0000244|PDB:4L87}.
FT   STRAND      315    317       {ECO:0000244|PDB:3VBB}.
FT   STRAND      319    330       {ECO:0000244|PDB:3VBB}.
FT   HELIX       336    354       {ECO:0000244|PDB:3VBB}.
FT   STRAND      359    363       {ECO:0000244|PDB:3VBB}.
FT   HELIX       366    368       {ECO:0000244|PDB:3VBB}.
FT   STRAND      374    383       {ECO:0000244|PDB:3VBB}.
FT   TURN        384    387       {ECO:0000244|PDB:3VBB}.
FT   STRAND      388    397       {ECO:0000244|PDB:3VBB}.
FT   HELIX       401    406       {ECO:0000244|PDB:3VBB}.
FT   STRAND      409    411       {ECO:0000244|PDB:3VBB}.
FT   STRAND      424    432       {ECO:0000244|PDB:3VBB}.
FT   HELIX       433    444       {ECO:0000244|PDB:3VBB}.
FT   STRAND      447    451       {ECO:0000244|PDB:3VBB}.
FT   HELIX       454    457       {ECO:0000244|PDB:3VBB}.
FT   STRAND      464    469       {ECO:0000244|PDB:3VBB}.
SQ   SEQUENCE   514 AA;  58777 MW;  F59DA8E55F193ACB CRC64;
     MVLDLDLFRV DKGGDPALIR ETQEKRFKDP GLVDQLVKAD SEWRRCRFRA DNLNKLKNLC
     SKTIGEKMKK KEPVGDDESV PENVLSFDDL TADALANLKV SQIKKVRLLI DEAILKCDAE
     RIKLEAERFE NLREIGNLLH PSVPISNDED VDNKVERIWG DCTVRKKYSH VDLVVMVDGF
     EGEKGAVVAG SRGYFLKGVL VFLEQALIQY ALRTLGSRGY IPIYTPFFMR KEVMQEVAQL
     SQFDEELYKV IGKGSEKSDD NSYDEKYLIA TSEQPIAALH RDEWLRPEDL PIKYAGLSTC
     FRQEVGSHGR DTRGIFRVHQ FEKIEQFVYS SPHDNKSWEM FEEMITTAEE FYQSLGIPYH
     IVNIVSGSLN HAASKKLDLE AWFPGSGAFR ELVSCSNCTD YQARRLRIRY GQTKKMMDKV
     EFVHMLNATM CATTRTICAI LENYQTEKGI TVPEKLKEFM PPGLQELIPF VKPAPIEQEP
     SKKQKKQHEG SKKKAAARDV TLENRLQNME VTDA
//
